首页> 外文期刊>Sleep medicine >Pharmacological and non-pharmacological management of sleep disturbance in children: An Australian Paediatric Research Network survey
【24h】

Pharmacological and non-pharmacological management of sleep disturbance in children: An Australian Paediatric Research Network survey

机译:儿童睡眠障碍的药理和非药理管理:澳大利亚儿科研究网络调查

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Australian paediatricians use a wide variety of practices when managing sleep disturbances in children, including use of melatonin and behavioral strategies. However, practice patterns around the use of strategies, dosing, and how the patient populations managed, are unknown. Results could inform guidelines for the management of child sleep disturbances. Objective: We aimed to document management practices by Australian general paediatricians for paediatric sleep disturbances through an online survey sent to members of the Australian Paediatric Research Network (APRN) who are recruited from the Royal Australasian College of Physicians. Results: 181 (49%) of 373 eligible paediatricians responded, with 101 prescribing melatonin. The most commonly prescribed medications for poor sleep initiation were melatonin (89.1%), clonidine (48%) and antihistamines (29%). Melatonin doses ranged from 0.5. mg to 12. mg and duration of treatment was as long as 200. weeks. Less than half of the paediatricians were aware of any potential melatonin side effects. Most paediatricians (82%) reported using behavioral strategies for sleep disturbances, most commonly anxiety relaxation techniques (75%) for poor sleep initiation and graduated extinction (i.e. " controlled crying" , 52%) for disrupted overnight sleep. Conclusions: Australian paediatricians use both pharmacological and non-pharmacological treatments for paediatric sleep disturbances. Melatonin is the most commonly prescribed medication, but wide variation in its prescribing suggests a lack of knowledge of recommended dosages and effectiveness. Given the prevalence and variation in prescribing, there is an urgent need to develop clear guidance for paediatricians managing children with sleep disturbance. ? 2012 Elsevier B.V.
机译:背景:澳大利亚的儿科医生在处理儿童的睡眠障碍时采用了多种做法,包括褪黑激素的使用和行为策略。但是,围绕策略的使用,剂量以及患者人群的管理方式的实践模式尚不清楚。结果可以为儿童睡眠障碍的治疗提供指导。目的:我们旨在通过在线调查,记录澳大利亚普通儿科医生针对儿童睡眠障碍的管理实践,该调查发送给从澳大利亚皇家医师学院招募的澳大利亚儿科研究网络(APRN)的成员。结果:373位合格的儿科医生中有181位(49%)做出了反应,其中101位处方了褪黑激素。睡眠不良最常用的处方药物是褪黑激素(89.1%),可乐定(48%)和抗组胺药(29%)。褪黑激素的剂量范围为0.5。毫克至12毫克,治疗时间长达200周。不到一半的儿科医生意识到任何潜在的褪黑激素副作用。大多数儿科医生(82%)表示使用行为策略治疗睡眠障碍,最常见的是焦虑放松技术(75%)用于睡眠不良,而渐进式灭绝(即“控制哭泣”,52%)用于过夜睡眠中断。结论:澳大利亚儿科医生同时使用药物和非药物疗法来治疗儿童睡眠障碍。褪黑激素是最常用的处方药,但其处方差异很大,提示缺乏对推荐剂量和功效的了解。考虑到处方的普遍性和差异性,迫切需要为治疗睡眠障碍儿童的儿科医生制定明确的指南。 ? 2012年Elsevier B.V.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号